234
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Neutrophil-to-Albumin Ratio as a New Predictor of All-Cause Mortality in Patients with Heart Failure

, , , , , ORCID Icon & show all
Pages 701-713 | Published online: 02 Feb 2022

References

  • Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200. doi:10.1093/eurheartj/ehw128
  • Tognini S, Pasqualetti G, Calsolaro V, Polini A, Caraccio N, Monzani F. Cardiovascular risk and quality of life in elderly people with mild thyroid hormone deficiency. Front Endocrinol (Lausanne). 2014;5:153. doi:10.3389/fendo.2014.00153
  • He T, Mischak M, Clark AL, et al. Urinary peptides in heart failure: a link to molecular pathophysiology. Eur J Heart Fail. 2021;23:1875–1887. doi:10.1002/ejhf.2195
  • Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7–11. doi:10.15420/cfr.2016:25:2
  • Park JJ, Choi DJ. Current status of heart failure: global and Korea. Korean J Intern Med. 2020;35(3):487–497. doi:10.3904/kjim.2020.120
  • Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Publisher Correction: reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2021;18:735. doi:10.1038/s41569-021-00534-3
  • Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018;52:8–12. doi:10.1016/j.ejim.2018.04.014
  • Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–437. doi:10.1111/j.0894-0959.2004.17603.x
  • Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783–1787. doi:10.1016/j.febslet.2008.04.057
  • Uthamalingam S, Kandala J, Daley M, et al. Serum albumin and mortality in acutely decompensated heart failure. Am Heart J. 2010;160(6):1149–1155. doi:10.1016/j.ahj.2010.09.004
  • Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008;155(5):883–889. doi:10.1016/j.ahj.2007.11.043
  • Gopal DM, Kalogeropoulos AP, Georgiopoulou VV, et al. Serum albumin concentration and heart failure risk the health, aging, and body composition study. Am Heart J. 2010;160(2):279–285. doi:10.1016/j.ahj.2010.05.022
  • Filippatos GS, Desai RV, Ahmed MI, et al. Hypoalbuminaemia and incident heart failure in older adults. Eur J Heart Fail. 2011;13(10):1078–1086. doi:10.1093/eurjhf/hfr088
  • Cui H, Ding X, Li W, Chen H, Li H. The neutrophil percentage to albumin ratio as a new predictor of in-hospital mortality in patients with ST-Segment elevation myocardial infarction. Med Sci Monit. 2019;25:7845–7852. doi:10.12659/MSM.917987
  • Wang B, Li D, Cheng B, Ying B, Gong Y. The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in critically ill patients with acute kidney injury. Biomed Res Int. 2020;2020:5687672. doi:10.1155/2020/5687672
  • Gong Y, Li D, Cheng B, Ying B, Wang B. Increased neutrophil percentage-to-albumin ratio is associated with all-cause mortality in patients with severe sepsis or septic shock. Epidemiol Infect. 2020;148:e87. doi:10.1017/S0950268820000771
  • Tawfik B, Mokdad AA, Patel PM, Li HC, Huerta S. The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiation. Anticancer Drugs. 2016;27(9):879–883. doi:10.1097/CAD.0000000000000411
  • Liao YC, Ying HQ, Huang Y, et al. Role of chronic inflammatory ratios in predicting recurrence of resected patients with Stage I-III mucinous colorectal adenocarcinoma. Cancer Manag Res. 2021;13:3455–3464. doi:10.2147/CMAR.S303758
  • Peng Y, Xue Y, Wang J, et al. Association between neutrophil-to-albumin ratio and mortality in patients with cardiogenic shock: a retrospective cohort study. BMJ Open. 2020;10(10):e039860. doi:10.1136/bmjopen-2020-039860
  • Johnson AE, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3:160035. doi:10.1038/sdata.2016.35
  • Mann DL, Deswal A, Bozkurt B, Torre-Amione G. New therapeutics for chronic heart failure. Annu Rev Med. 2002;53:59–74. doi:10.1146/annurev.med.53.082901.104004
  • Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334(21):1349–1355. doi:10.1056/NEJM199605233342101
  • Merit HF; International Steering Committee. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure. Lancet. 1999;353(9169):2001–2007. doi:10.1016/S0140-6736(99)04440-2
  • FaBbender K, Mielke O. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353(9146):9–13. doi:10.1016/S0140-6736(98)11181-9
  • Van Linthout S, Tschope C. Inflammation - cause or consequence of heart failure or both? Curr Heart Fail Rep. 2017;14(4):251–265. doi:10.1007/s11897-017-0337-9
  • Rullman E, Melin M, Mandic M, Gonon A, Fernandez-Gonzalo R, Gustafsson T. Circulatory factors associated with function and prognosis in patients with severe heart failure. Clin Res Cardiol. 2020;109(6):655–672. doi:10.1007/s00392-019-01554-3
  • Smith JA. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol. 1994;56(6):672–686. doi:10.1002/jlb.56.6.672
  • Niessner A, Hohensinner PJ, Rychli K, et al. Prognostic value of apoptosis markers in advanced heart failure patients. Eur Heart J. 2009;30(7):789–796. doi:10.1093/eurheartj/ehp004
  • Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol. 2020;17(6):327–340. doi:10.1038/s41569-019-0326-7
  • Bai B, Cheng M, Jiang L, Xu J, Chen H, Xu Y. High neutrophil to lymphocyte ratio and its gene signatures correlate with diastolic dysfunction in heart failure with preserved ejection fraction. Front Cardiovasc Med. 2021;8:614757. doi:10.3389/fcvm.2021.614757
  • Fuhrman MP, Charney P, Mueller CM. Hepatic proteins and nutrition assessment. J Am Diet Assoc. 2004;104(8):1258–1264. doi:10.1016/j.jada.2004.05.213
  • De Feo P, Lucidi P. Liver protein synthesis in physiology and in disease states. Curr Opin Clin Nutr Metab Care. 2002;5(1):47–50. doi:10.1097/00075197-200201000-00009
  • Mitch WE. Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest. 2002;110(4):437–439. doi:10.1172/JCI16494
  • Pasini E, Aquilani R, Gheorghiade M, Dioguardi FS. Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach. Ital Heart J. 2003;4(4):232–235.
  • Liu M, Chan CP, Yan BP, et al. Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2012;14(1):39–44. doi:10.1093/eurjhf/hfr154
  • Arques S, Ambrosi P. Human serum albumin in the clinical syndrome of heart failure. J Card Fail. 2011;17(6):451–458. doi:10.1016/j.cardfail.2011.02.010
  • Pasini E, Comini L, Dioguardi FS, et al. Hypoalbuminemia as a marker of protein metabolism disarrangement in patients with stable chronic heart failure. Minerva Med. 2020;111(3):226–238. doi:10.23736/S0026-4806.20.06244-8